StockWatch
·
Pharmaceuticals
Promoter Reclassification4 Sept 2026, 01:31 pm

Hester Biosciences Shareholders Approve Promoter Reclassification

AI Summary

Hester Biosciences Ltd announced that its shareholders have approved the reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from the Promoter and Promoter Group category to the Public Category. This decision was made via an ordinary resolution passed through postal ballot on September 3, 2026, in accordance with SEBI Listing Regulations. The individuals will no longer be reported as part of the Promoter Shareholders in future shareholding patterns. The company has received no-objection letters from BSE and NSE for this reclassification. The resolution confirms that the reclassified individuals meet SEBI's criteria, including not holding more than 10% of equity, not exercising control, and not having special rights or board representation.

Key Highlights

  • Shareholders approved reclassification of two individuals from Promoter to Public category.
  • Reclassification is in compliance with SEBI Listing Regulations.
  • Individuals will no longer be part of Promoter shareholding disclosures.
  • No-objection received from BSE and NSE for the reclassification.
  • Reclassified individuals meet SEBI's criteria for public shareholders.